Products

Products

Rabies Vaccine Vero Cell For Human Immunization Use

Rabies Vaccine Vero Cell For Human Immunization Use, supplied by AIM Honor (Ningbo) Biopharmaceutical Co., Ltd., is developed for reliable human rabies prevention with advanced Vero cell culture technology. As a professional China vaccine manufacturer, AIM Honor provides high-quality vaccine solutions featuring a 100% antibody seroconversion rate within 14 days, no preservatives or antibiotics, and stable GMP production capability to support global immunization programs.

AIM Honor is a trusted supplier of Rabies Vaccine Vero Cell For Human Immunization Use, offering purified inactivated rabies vaccine solutions designed for pre-exposure and post-exposure immunization. The product follows strict quality control procedures and is manufactured according to pharmaceutical production requirements to provide dependable protection against rabies virus infection.

Product Overview

Rabies is a serious viral disease that requires timely and effective preventive measures after exposure or before potential contact with the virus. AIM Honor’s vaccine solution is designed based on Vero cell culture technology, using an inactivated rabies fixed virus (aGV strain) as the active ingredient. The vaccine is formulated as a freeze-dried preparation and supplied with sterile water for injection for clinical use.

The Rabies Vaccine Vero Cell For Human Immunization Use is developed for human immunization needs, helping recipients establish immunity against rabies virus following vaccination. It is suitable for different vaccination scenarios, including people exposed to suspected rabid animals and individuals with occupational risks of rabies virus contact.

Composition And Characteristics

The vaccine is produced through cultivation of rabies fixed virus in Vero cells. After virus cultivation and harvest, the suspension undergoes inactivation, concentration, purification, and freeze-drying processes with stabilizing components added to maintain product quality.

The finished product appears as a white freeze-dried cake. After reconstitution with sterile water for injection, it becomes a clear liquid suitable for intramuscular administration.

Key composition information includes:

1. Active ingredient: Inactivated rabies fixed virus.

2. Excipients: 1% human albumin, 1% gelatin, and 5% sucrose.

3. Diluent: Sterile water for injection.

The formulation does not contain preservatives, providing an additional advantage for customers seeking reliable human rabies vaccine products with controlled composition.

Technical Specifications

AIM Honor maintains strict production and quality management procedures throughout manufacturing. The product specifications are designed according to pharmaceutical standards to ensure consistency between batches.

Product Name Rabies Vaccine Vero Cell For Human Immunization Use
Type Freeze-dried inactivated rabies vaccine
Virus Strain Rabies fixed virus (aGV strain)
Cell Culture System Vero cell technology
Dosage Form Lyophilized injection
Single Human Dose 1.0 ml after reconstitution
Potency Not less than 2.51U
Storage Condition Store and transport between +2 °C and +8 °C, protected from light
Validity Period 36 months

Production Advantages

AIM Honor focuses on pharmaceutical manufacturing capability and quality management. The production process of the vaccine integrates advanced purification methods, controlled clean environments, and standardized manufacturing procedures to maintain product stability and reliability.

The manufacturing advantages include:

1. Advanced purification process: The production process adopts a 20m² ultrafiltration system and a 600mm chromatography system for multi-step purification. This process helps remove foreign proteins, DNA, and other impurities while maintaining antigen quality.

2. Strict quality control: Internal quality standards are controlled more strictly than national pharmacopoeia requirements. Quality testing includes endotoxin control ≤10EU/dose, sterility testing, and pH value management.

3. Professional freeze-drying technology: A 40m² freeze-drying system is used during preparation. The process helps reduce moisture content, maintain antigen activity, and improve product stability during storage.

Rabies Vaccine Vero Cell For Human Immunization Use

Manufacturing Environment

The production process is completed in a controlled B+A grade clean environment. The bacterial culture and passage procedures are performed through closed sterile operation systems to reduce contamination risks.

The professional production team follows standardized operating procedures and uses high-precision equipment to control important parameters such as temperature and pH. These procedures support stable strain activity and consistent vaccine antigen quality.

Rabies Vaccine Vero Cell For Human Immunization Use

Immunization Applications

The Rabies Vaccine Vero Cell For Human Immunization Use is designed for human rabies prevention through professional vaccination procedures. It can be applied in both pre-exposure and post-exposure immunization programs according to medical recommendations and applicable vaccination guidelines.

Post Exposure Prevention

When a person is bitten or scratched by a suspected rabid animal, immediate wound cleaning and timely vaccination are important steps for rabies prevention. Regardless of age or gender, exposed individuals should receive appropriate medical evaluation and vaccination according to the recommended schedule.

The post-exposure immunization procedure generally includes vaccine administration on days 0, 3, 7, 14, and 28, with five doses in total. The final vaccination plan should be determined according to exposure conditions and healthcare professional advice.

Pre Exposure Immunization

People who have a higher possibility of contacting rabies virus during their work or daily activities may require preventive immunization before exposure. These groups may include:

1. Veterinarians and animal breeders who frequently contact animals.

2. Forestry workers and slaughterhouse staff with occupational exposure risks.

3. Laboratory personnel involved in rabies-related research or testing.

For pre-exposure vaccination, a total of three doses are administered according to the specified schedule on days 0, 7, and 21 or 28.

Usage Guidance

Proper administration is an important part of achieving effective immunization. Healthcare professionals should follow approved procedures when preparing and administering the vaccine.

1. Vaccine preparation: Reconstitute the freeze-dried vaccine with the enclosed sterile water for injection and shake thoroughly before use.

2. Injection method: The vaccine is administered through intramuscular injection. For adults and older children, the recommended injection site is the deltoid muscle of the upper arm. For young children, administration can be performed in the anterolateral thigh muscle according to professional guidance.

3. Professional supervision: Vaccination should be performed by qualified medical personnel who can evaluate individual conditions and provide appropriate medical advice.

Safety And Quality

AIM Honor emphasizes product safety, manufacturing consistency, and quality management throughout the vaccine production process. The Rabies Vaccine Vero Cell For Human Immunization Use follows controlled production procedures to ensure reliable quality for global healthcare applications.

The vaccine production process includes multiple quality management steps:

1. Purification control: Advanced purification technology is applied to improve antigen purity and remove unwanted components generated during production.

2. Sterility management: Production operations are conducted under controlled clean conditions with strict monitoring procedures.

3. Stability protection: Freeze-drying technology helps maintain product quality and supports storage stability under recommended conditions.

Rabies Vaccine Vero Cell For Human Immunization Use

Possible Reactions

Like other vaccines, this product may cause temporary reactions after administration. Common reactions may include redness, swelling, pain, or itching at the injection site, which usually improve naturally.

Some recipients may experience temporary systemic reactions such as low fever, fatigue, headache, dizziness, joint discomfort, muscle pain, vomiting, or stomach discomfort.

Rare reactions may include allergic symptoms. Individuals receiving vaccination should follow medical guidance and seek professional assistance if unusual symptoms occur.

Storage And Supply

Maintaining proper storage conditions is essential for preserving vaccine quality. The product should be stored and transported between +2 °C and +8 °C while avoiding direct light exposure.

AIM Honor provides professional supply support for international customers requiring stable vaccine procurement. With pharmaceutical manufacturing experience and quality-focused production management, the company supports cooperation with distributors, healthcare organizations, and global partners.

Rabies Vaccine Vero Cell For Human Immunization Use

Why Choose AIM Honor

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on vaccine research, development, manufacturing, and global supply services. The company has established professional production facilities and quality management systems to support reliable pharmaceutical products.

Choosing AIM Honor means working with a manufacturer that values:

1. Professional biopharmaceutical production capability.

2. Controlled manufacturing processes based on GMP requirements.

3. Stable supply support for international cooperation.

4. Technical communication and professional customer service.

The combination of production technology, quality management, and international cooperation experience makes AIM Honor a reliable partner for customers seeking human rabies vaccine solutions.

FAQ

Q: What is Rabies Vaccine Vero Cell For Human Immunization Use?

A: Rabies Vaccine Vero Cell For Human Immunization Use is a freeze-dried inactivated rabies vaccine produced using Vero cell culture technology. It is designed to help humans develop immunity against rabies virus after vaccination.

Q: Who needs this vaccine?

A: The vaccine can be used for people requiring rabies prevention, including individuals exposed to suspected rabid animals and people with occupational risks such as veterinarians, animal breeders, forestry workers, slaughterhouse workers, and laboratory personnel.

Q: What is the storage condition of this vaccine?

A: The vaccine should be stored and transported at +2 °C to +8 °C and protected from light. The validity period is 36 months under recommended storage conditions.

Q: Does the vaccine contain preservatives?

A: The product formulation does not contain preservatives. The composition includes inactivated rabies fixed virus, human albumin, gelatin, sucrose, and sterile water for injection.

Q: What injection method is used?

A: The vaccine is administered by intramuscular injection. The specific injection site and vaccination schedule should follow professional medical guidance.

Q: Can AIM Honor provide international supply services?

A: AIM Honor provides professional pharmaceutical supply cooperation services and supports communication with global customers requiring reliable vaccine products.

Conclusion

With advanced Vero cell culture technology, controlled manufacturing procedures, and professional quality management, AIM Honor’s Rabies Vaccine Vero Cell For Human Immunization Use provides a dependable solution for human rabies prevention. The combination of stable production capability, strict quality control, and international supply support helps healthcare partners access reliable vaccine products for different immunization needs.

Rabies Vaccine Vero Cell For Human Immunization Use

Hot Products

  • Liver Cancer Prevention Vaccine

    Liver Cancer Prevention Vaccine

    The Liver Cancer Prevention Vaccine is one of the products offered by AIM Honesty Biopharmaceutical Co., Ltd. We are a supplier with comprehensive R&D capabilities, and through cooperation with us, you can obtain advanced and highly effective vaccine products for the control of hepatitis infectious diseases and even more serious liver cancer through economical and effective immunization methods.
  • Vaccine for Rabies After Bite

    Vaccine for Rabies After Bite

    AIM Honor (Ningbo) Biopharmaceutical Co., Ltd., as a professional rabies vaccine manufacturer, offers Vaccine for Rabies After Bite, a specialized emergency immunization product for Category II/III exposures after dog bites. It covers two main categories: conventional Vero cell rabies vaccine and the next-generation serum-free Vero cell rabies vaccine.
  • Meningococcal Polysaccharide Vaccine

    Meningococcal Polysaccharide Vaccine

    Meningococcal Polysaccharide Vaccine is a product developed by AIM Persistence Biopharmaceutical Co., Ltd. As a reliable vaccine manufacturer, we provide a core means of preventing meningococcal meningitis, achieving a breakthrough based on conventional meningococcal polysaccharide vaccines, offering safer protection.
  • Children Meningitis Vaccine

    Children Meningitis Vaccine

    AIM Persistence Biopharmaceutical Co., Ltd. is a reliable manufacturer and supplier of Children Meningitis Vaccine. Our Xin'er Cong® series features multiple serotypes, high seroconversion rates, low residual rates, and a long shelf life. It contains no preservatives or antibiotics, ensuring excellent product safety.
  • Human Diploid Hepatitis A Vaccine

    Human Diploid Hepatitis A Vaccine

    If you are looking for a manufacturer that can provide a stable, long-term supply of Human Diploid Hepatitis A Vaccine, you can choose AIM Action Biopharmaceutical Co., Ltd. from China. We produce vaccines using internationally recognized safe human diploid cells (KMB17) as the culture medium, eliminating the potential risk of viral contamination and tumorigenicity associated with animal-derived cells, resulting in a purer and safer product.
  • W-Type Meningitis Vaccine

    W-Type Meningitis Vaccine

    If you need a reliable supplier of W-Type Meningitis Vaccine, consider AIM Persistence Biopharmaceutical Co., Ltd. We are a Chinese company that develops vaccines using advanced domestic and international technologies. Our Xin'er Cong® series is an upgraded vaccine developed to address the threat of multiple serotypes of meningococcal meningitis, including W-type. It effectively prevents infection from four serotypes of meningococcal bacteria: A, C, Y, and W135 (W-type).

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
RejectAccept